Breakthrough Seed Funding Awardees
The purpose of the CARE Fund’s Breakthrough Seed Funding grant is to encourage and support life science companies, entrepreneurs, innovators, and researchers who seek to explore and develop innovative ideas and strategies to substantially advance cancer research and care from etiology to survivorship. Such projects may be high risk but must have the potential for high impact breakthroughs in cancer research and care that will extend understanding or uncover new pathways beyond the span of the project.
Cycle 1
May 2023
Unraveling Tumor-Immune Microenvironment by a Novel Spatial Assay Registering Cellular Metabolic Functions with Underlying Omic Profiles at Single-Cell Resolution
Institute for Systems Biology (Principal Investigator: Wei Wei, PhD)An AI-based Platform Cytogenomic Risk Assessment in Colorectal Carcinoma
Phase Genomics, Inc. (Principal Investigator: Stephen Eacker, PhD)Developing Adoptive Cell Therapy Engineering Strategies to Catalyze and Diversify Endogenous Antitumor Immune Responses
Seattle Children’s Research Institute (Principal Investigator: Shannon Oda, PhD)Role of Complement C3 in Kidney Cancer
University of Washington (Principal Investigator: Christopher Blosser, MD; Shreeram Akilesh, MD, PhD)A Synthetic Genetic Platform to Deliver Higher Precision Care for Recurrent or Refractory Cancers with Wnt Pathway Activation
University of Washington (Principal Investigator: Jennifer Nemhauser, PhD)Selective Glycolysis Inhibitors (SGIs): Enabling Clinical Development of Novel Small Molecules for the Treatment of Advanced Prostate Cancer
University of Washington (Principal Investigator: Wesley Van Voorhis, MD, PhD)